AMRI Signs Supply Agreement with AstraZeneca to Manufacture COVID-19 Vaccine
XTalks
SEPTEMBER 8, 2020
The company has signed on to help manufacture AstraZeneca’s COVID-19 vaccine candidate, AZD1222, intended to protect against the SARS-CoV-2 novel coronavirus. AMRI is proud to partner with AstraZeneca in pursuit of a vaccine that could protect people against the coronavirus pandemic,” said John Ratliff, CEO of AMRI, in a statement.
Let's personalize your content